112 related articles for article (PubMed ID: 9295281)
1. Protein kinase CbetaII activation by 1-beta-D-arabinofuranosylcytosine is antagonistic to stimulation of apoptosis and Bcl-2alpha down-regulation.
Whitman SP; Civoli F; Daniel LW
J Biol Chem; 1997 Sep; 272(38):23481-4. PubMed ID: 9295281
[TBL] [Abstract][Full Text] [Related]
2. Agents that down-regulate or inhibit protein kinase C circumvent resistance to 1-beta-D-arabinofuranosylcytosine-induced apoptosis in human leukemia cells that overexpress Bcl-2.
Wang S; Vrana JA; Bartimole TM; Freemerman AJ; Jarvis WD; Kramer LB; Krystal G; Dent P; Grant S
Mol Pharmacol; 1997 Dec; 52(6):1000-9. PubMed ID: 9396780
[TBL] [Abstract][Full Text] [Related]
3. Potentiation of ara-C-induced apoptosis by the protein kinase C activator bryostatin 1 in human leukemia cells (HL-60) involves a process dependent upon c-Myc.
Chelliah J; Freemerman AJ; Wu-Pong S; Jarvis WD; Grant S
Biochem Pharmacol; 1997 Sep; 54(5):563-73. PubMed ID: 9337072
[TBL] [Abstract][Full Text] [Related]
4. Evidence for involvement of mitogen-activated protein kinase, rather than stress-activated protein kinase, in potentiation of 1-beta-D-arabinofuranosylcytosine-induced apoptosis by interruption of protein kinase C signaling.
Jarvis WD; Fornari FA; Tombes RM; Erukulla RK; Bittman R; Schwartz GK; Dent P; Grant S
Mol Pharmacol; 1998 Nov; 54(5):844-56. PubMed ID: 9804619
[TBL] [Abstract][Full Text] [Related]
5. Bryostatin 1 and UCN-01 potentiate 1-beta-D-arabinofuranosylcytosine-induced apoptosis in human myeloid leukemia cells through disparate mechanisms.
Wang S; Wang Z; Grant S
Mol Pharmacol; 2003 Jan; 63(1):232-42. PubMed ID: 12488556
[TBL] [Abstract][Full Text] [Related]
6. Resistance of human leukemic cell lines to 1-beta-D-arabinofuranosylcytosine: characterization of an experimental model.
Gariboldi MB; Ravizza R; Marras E; Perletti G; De Simone A; Piccinini F; Monti E
Int J Oncol; 2001 Jun; 18(6):1245-9. PubMed ID: 11351258
[TBL] [Abstract][Full Text] [Related]
7. Quaternary ammonium analogs of ether lipids inhibit the activation of protein kinase C and the growth of human leukemia cell lines.
Civoli F; Daniel LW
Cancer Chemother Pharmacol; 1998; 42(4):319-26. PubMed ID: 9744778
[TBL] [Abstract][Full Text] [Related]
8. ET-18-OCH3 inhibits nuclear factor-kappa B activation by 12-O-tetradecanoylphorbol-13-acetate but not by tumor necrosis factor-alpha or interleukin 1 alpha.
Daniel LW; Civoli F; Rogers MA; Smitherman PK; Raju PA; Roederer M
Cancer Res; 1995 Nov; 55(21):4844-9. PubMed ID: 7585518
[TBL] [Abstract][Full Text] [Related]
9. Involvement of c-Jun NH2-terminal kinase activation and c-Jun in the induction of apoptosis by the ether phospholipid 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine.
Gajate C; Santos-Beneit A; Modolell M; Mollinedo F
Mol Pharmacol; 1998 Apr; 53(4):602-12. PubMed ID: 9547349
[TBL] [Abstract][Full Text] [Related]
10. Enforced expression of Bcl-XS induces differentiation and sensitizes chronic myelogenous leukemia-blast crisis K562 cells to 1-beta-D-arabinofuranosylcytosine-mediated differentiation and apoptosis.
Ray S; Bullock G; Nuñez G; Tang C; Ibrado AM; Huang Y; Bhalla K
Cell Growth Differ; 1996 Dec; 7(12):1617-23. PubMed ID: 8959329
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of calcium-dependent protein kinase C by hexadecylphosphocholine and 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine do not correlate with inhibition of proliferation of HL60 and K562 cell lines.
Berkovic D; Berkovic K; Fleer EA; Eibl H; Unger C
Eur J Cancer; 1994; 30A(4):509-15. PubMed ID: 8018410
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of Bcl-2 or Bcl-xL inhibits Ara-C-induced CPP32/Yama protease activity and apoptosis of human acute myelogenous leukemia HL-60 cells.
Ibrado AM; Huang Y; Fang G; Liu L; Bhalla K
Cancer Res; 1996 Oct; 56(20):4743-8. PubMed ID: 8840993
[TBL] [Abstract][Full Text] [Related]
13. 1-beta-D-arabinofuranosylcytosine activates serine/threonine protein kinases and c-jun gene expression in phorbol ester-resistant myeloid leukemia cells.
Kharbanda S; Emoto Y; Kisaki H; Saleem A; Kufe D
Mol Pharmacol; 1994 Jul; 46(1):67-72. PubMed ID: 8058058
[TBL] [Abstract][Full Text] [Related]
14. Ether lipids inhibit the effects of phorbol diester tumor promoters.
Daniel LW; Etkin LA; Morrison BT; Parker J; Morris-Natschke S; Surles JR; Piantadosi C
Lipids; 1987 Nov; 22(11):851-5. PubMed ID: 3444377
[TBL] [Abstract][Full Text] [Related]
15. Effect of novel modulators of protein kinase C activity upon chemotherapy-induced differentiation and apoptosis in myeloid leukemic cells.
Meinhardt G; Eppinger E; Schmidmaier R
Anticancer Drugs; 2002 Aug; 13(7):725-33. PubMed ID: 12187329
[TBL] [Abstract][Full Text] [Related]
16. Heregulin-induced apoptosis is mediated by down-regulation of Bcl-2 and activation of caspase-7 and is potentiated by impairment of protein kinase C alpha activity.
Le XF; Marcelli M; McWatters A; Nan B; Mills GB; O'Brian CA; Bast RC
Oncogene; 2001 Dec; 20(57):8258-69. PubMed ID: 11781840
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of protein kinase C by ether-linked lipids is not correlated with their antineoplastic activity on WEHI-3B and R6X-B15 cells.
Salari H; Dryden P; Davenport R; Howard S; Jones K; Bittman R
Biochim Biophys Acta; 1992 Feb; 1134(1):81-8. PubMed ID: 1543759
[TBL] [Abstract][Full Text] [Related]
18. Effects of bryostatin 1 and other pharmacological activators of protein kinase C on 1-[beta-D-arabinofuranosyl]cytosine-induced apoptosis in HL-60 human promyelocytic leukemia cells.
Jarvis WD; Povirk LF; Turner AJ; Traylor RS; Gewirtz DA; Pettit GR; Grant S
Biochem Pharmacol; 1994 Mar; 47(5):839-52. PubMed ID: 8135859
[TBL] [Abstract][Full Text] [Related]
19. Modulation of protein kinase C activity and calcium-sensitive isoform expression in human myeloid leukemia cells by bryostatin 1: relationship to differentiation and ara-C-induced apoptosis.
Grant S; Turner AJ; Freemerman AJ; Wang Z; Kramer L; Jarvis WD
Exp Cell Res; 1996 Oct; 228(1):65-75. PubMed ID: 8892972
[TBL] [Abstract][Full Text] [Related]
20. Effects of bryostatin 1 and calcium ionophore (A23187) on apoptosis and differentiation in human myeloid leukemia cells (HL-60) following 1-beta-D-arabinofuranosylcytosine exposure.
Vrana JA; Rao AS; Wang Z; Jarvis WD; Grant S
Int J Oncol; 1998 Apr; 12(4):927-34. PubMed ID: 9499457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]